Details for 2019824224
Up to date per 02.04.2026
Actions
Details for 2019824224
Granted/Registered
European Patent
06.10.2021 A
08.05.2024 B1
30.11.2018
US
201862774164 P
06.12.2018
US
201862776415 P
14.05.2019
US
201962847926 P
30.05.2019
US
201962854945 P
22.08.2019
US
201962890600 P
05.11.2019
US
201962931204 P
A61K 35/17 20150101AFI20231108BHEP
Owner
Juno Therapeutics, Inc.400 Dexter Ave. N Suite 1200 Seattle, WA 98109-4703US
Representative
Representative
Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT
Inventor
ALBERTSON, Tinac/o Juno Therapeutics, Inc. 400 Dexter Ave. N Suite 1200 Seattle, Washington 98109-4703US
GARCIA, Jacob Randolphc/o Juno Therapeutics, Inc. 400 Dexter Ave. N Suite 1200 Seattle, Washington 98109-4703US
GILBERT, Markc/o Juno Therapeutics, Inc. 400 Dexter Ave. N Suite 1200 Seattle, Washington 98109-4703US
LI, Hec/o Juno Therapeutics, Inc. 400 Dexter Ave. N Suite 1200 Seattle, Washington 98109-4703US
SUTHERLAND, Clairec/o Juno Therapeutics, Inc. 400 Dexter Ave. N Suite 1200 Seattle, Washington 98109-4703US
TREDE, Nikolaus Sebastian400 Dexter Ave. N Suite 1200 Seattle, Washington 98109US
Information about Fees